Characterization of innate responses to influenza virus infection in a novel lung type I epithelial cell model Free

Abstract

Type I alveolar epithelial cells are a replicative niche for influenza , yet their response to infection is not fully understood. To better characterize their cellular responses, we have created an immortalized murine lung epithelial type I cell line (LET1). These cells support spreading influenza virus infection in the absence of exogenous protease and thus permit simultaneous analysis of viral replication dynamics and host cell responses. LET1 cells can be productively infected with human, swine and mouse-adapted strains of influenza virus and exhibit expression of an antiviral transcriptional programme and robust cytokine secretion. We characterized influenza virus replication dynamics and host responses of lung type I epithelial cells and identified the capacity of epithelial cell-derived type I IFN to regulate specific modules of antiviral effectors to establish an effective antiviral state. Together, our results indicate that the type I epithelial cell can play a major role in restricting influenza virus infection without contribution from the haematopoietic compartment.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.058438-0
2014-02-01
2024-03-28
Loading full text...

Full text loading...

/deliver/fulltext/jgv/95/2/350.html?itemId=/content/journal/jgv/10.1099/vir.0.058438-0&mimeType=html&fmt=ahah

References

  1. Agarwal V., Asmat T. M., Luo S., Jensch I., Zipfel P. F., Hammerschmidt S. 2010; Complement regulator Factor H mediates a two-step uptake of Streptococcus pneumoniae by human cells. J Biol Chem 285:23486–23495 [View Article][PubMed]
    [Google Scholar]
  2. Arnheiter H., Skuntz S., Noteborn M., Chang S., Meier E. 1990; Transgenic mice with intracellular immunity to influenza virus. Cell 62:51–61 [View Article][PubMed]
    [Google Scholar]
  3. Barchet W., Cella M., Odermatt B., Asselin-Paturel C., Colonna M., Kalinke U. 2002; Virus-induced interferon alpha production by a dendritic cell subset in the absence of feedback signaling in vivo . J Exp Med 195:507–516 [View Article][PubMed]
    [Google Scholar]
  4. Bertram S., Glowacka I., Steffen I., Kühl A., Pöhlmann S. 2010a; Novel insights into proteolytic cleavage of influenza virus hemagglutinin. Rev Med Virol 20:298–310 [View Article][PubMed]
    [Google Scholar]
  5. Bertram S., Glowacka I., Blazejewska P., Soilleux E., Allen P., Danisch S., Steffen I., Choi S.-Y., Park Y. other authors 2010b; TMPRSS2 and TMPRSS4 facilitate trypsin-independent spread of influenza virus in Caco-2 cells. J Virol 84:10016–10025 [View Article][PubMed]
    [Google Scholar]
  6. Böttcher E., Matrosovich T., Beyerle M., Klenk H.-D., Garten W., Matrosovich M. 2006; Proteolytic activation of influenza viruses by serine proteases TMPRSS2 and HAT from human airway epithelium. J Virol 80:9896–9898 [View Article][PubMed]
    [Google Scholar]
  7. Böttcher E., Freuer C., Steinmetzer T., Klenk H.-D., Garten W. 2009; MDCK cells that express proteases TMPRSS2 and HAT provide a cell system to propagate influenza viruses in the absence of trypsin and to study cleavage of HA and its inhibition. Vaccine 27:6324–6329 [View Article][PubMed]
    [Google Scholar]
  8. Böttcher-Friebertshäuser E., Freuer C., Sielaff F., Schmidt S., Eickmann M., Uhlendorff J., Steinmetzer T., Klenk H.-D., Garten W. 2010; Cleavage of influenza virus hemagglutinin by airway proteases TMPRSS2 and HAT differs in subcellular localization and susceptibility to protease inhibitors. J Virol 84:5605–5614 [View Article][PubMed]
    [Google Scholar]
  9. Böttcher-Friebertshäuser E., Stein D. A., Klenk H.-D., Garten W. 2011; Inhibition of influenza virus infection in human airway cell cultures by an antisense peptide-conjugated morpholino oligomer targeting the hemagglutinin-activating protease TMPRSS2. J Virol 85:1554–1562 [View Article][PubMed]
    [Google Scholar]
  10. Byfield F. J., Kowalski M., Cruz K., Leszczyńska K., Namiot A., Savage P. B., Bucki R., Janmey P. A. 2011; Cathelicidin LL-37 increases lung epithelial cell stiffness, decreases transepithelial permeability, and prevents epithelial invasion by Pseudomonas aeruginosa . J Immunol 187:6402–6409 [View Article][PubMed]
    [Google Scholar]
  11. Chan M. C. W., Chan R. W. Y., Yu W. C. L., Ho C. C. C., Yuen K. M., Fong J. H. M., Tang L. L. S., Lai W. W., Lo A. C. Y. other authors 2010; Tropism and innate host responses of the 2009 pandemic H1N1 influenza virus in ex vivo and in vitro cultures of human conjunctiva and respiratory tract. Am J Pathol 176:1828–1840 [View Article][PubMed]
    [Google Scholar]
  12. Crapo J. D., Barry B. E., Gehr P., Bachofen M., Weibel E. R. 1982; Cell number and cell characteristics of the normal human lung. Am Rev Respir Dis 126:332–337[PubMed]
    [Google Scholar]
  13. Dash P., Barnett P. V., Denyer M. S., Jackson T., Stirling C. M. A., Hawes P. C., Simpson J. L., Monaghan P., Takamatsu H.-H. 2010; Foot-and-mouth disease virus replicates only transiently in well-differentiated porcine nasal epithelial cells. J Virol 84:9149–9160 [View Article][PubMed]
    [Google Scholar]
  14. Desvignes L., Ernst J. D. 2009; Interferon-gamma-responsive nonhematopoietic cells regulate the immune response to Mycobacterium tuberculosis . Immunity 31:974–985 [View Article][PubMed]
    [Google Scholar]
  15. Ehlers S. 2009; Lazy, dynamic or minimally recrudescent? On the elusive nature and location of the mycobacterium responsible for latent tuberculosis. Infection 37:87–95 [View Article][PubMed]
    [Google Scholar]
  16. Feeley E. M., Sims J. S., John S. P., Chin C. R., Pertel T., Chen L.-M., Gaiha G. D., Ryan B. J., Donis R. O. other authors 2011; IFITM3 inhibits influenza A virus infection by preventing cytosolic entry. PLoS Pathog 7:e1002337 [View Article][PubMed]
    [Google Scholar]
  17. Fumagalli O., Tall B. D., Schipper C., Oelschlaeger T. A. 1997; N-glycosylated proteins are involved in efficient internalization of Klebsiella pneumoniae by cultured human epithelial cells. Infect Immun 65:4445–4451[PubMed]
    [Google Scholar]
  18. Garzoni C., Francois P., Huyghe A., Couzinet S., Tapparel C., Charbonnier Y., Renzoni A., Lucchini S., Lew D. P. other authors 2007; A global view of Staphylococcus aureus whole genome expression upon internalization in human epithelial cells. BMC Genomics 8:171 [View Article][PubMed]
    [Google Scholar]
  19. Génin P., Lin R., Hiscott J., Civas A. 2009; Differential regulation of human interferon A gene expression by interferon regulatory factors 3 and 7. Mol Cell Biol 29:3435–3450 [View Article][PubMed]
    [Google Scholar]
  20. Haller O., Arnheiter H., Gresser I., Lindenmann J. 1979; Genetically determined, interferon-dependent resistance to influenza virus in mice. J Exp Med 149:601–612 [View Article][PubMed]
    [Google Scholar]
  21. Haller O., Staeheli P., Kochs G. 2007; Interferon-induced Mx proteins in antiviral host defense. Biochimie 89:812–818 [View Article][PubMed]
    [Google Scholar]
  22. Hashimoto Y., Moki T., Takizawa T., Shiratsuchi A., Nakanishi Y. 2007; Evidence for phagocytosis of influenza virus-infected, apoptotic cells by neutrophils and macrophages in mice. J Immunol 178:2448–2457[PubMed] [CrossRef]
    [Google Scholar]
  23. Herold S., von Wulffen W., Steinmueller M., Pleschka S., Kuziel W. A., Mack M., Srivastava M., Seeger W., Maus U. A., Lohmeyer J. 2006; Alveolar epithelial cells direct monocyte transepithelial migration upon influenza virus infection: impact of chemokines and adhesion molecules. J Immunol 177:1817–1824[PubMed] [CrossRef]
    [Google Scholar]
  24. Hirakata Y., Finlay B. B., Simpson D. A., Kohno S., Kamihira S., Speert D. P. 2000; Penetration of clinical isolates of Pseudomonas aeruginosa through MDCK epithelial cell monolayers. J Infect Dis 181:765–769 [View Article][PubMed]
    [Google Scholar]
  25. Hirakata Y., Srikumar R., Poole K., Gotoh N., Suematsu T., Kohno S., Kamihira S., Hancock R. E. W., Speert D. P. 2002; Multidrug efflux systems play an important role in the invasiveness of Pseudomonas aeruginosa . J Exp Med 196:109–118 [View Article][PubMed]
    [Google Scholar]
  26. Ilyushina N. A., Khalenkov A. M., Seiler J. P., Forrest H. L., Bovin N. V., Marjuki H., Barman S., Webster R. G., Webby R. J. 2010; Adaptation of pandemic H1N1 influenza viruses in mice. J Virol 84:8607–8616 [View Article][PubMed]
    [Google Scholar]
  27. Isaacs A., Lindenmann J. 1987; Virus interference. I. The interferon. By A. Isaacs and J. Lindenmann, 1957. J Interferon Res 7:429–438 [View Article][PubMed]
    [Google Scholar]
  28. Kato A., Sakai Y., Shioda T., Kondo T., Nakanishi M., Nagai Y. 1996; Initiation of Sendai virus multiplication from transfected cDNA or RNA with negative or positive sense. Genes Cells 1:569–579 [View Article][PubMed]
    [Google Scholar]
  29. Kato H., Sato S., Yoneyama M., Yamamoto M., Uematsu S., Matsui K., Tsujimura T., Takeda K., Fujita T. other authors 2005; Cell type-specific involvement of RIG-I in antiviral response. Immunity 23:19–28 [View Article][PubMed]
    [Google Scholar]
  30. Kumagai Y., Takeuchi O., Kato H., Kumar H., Matsui K., Morii E., Aozasa K., Kawai T., Akira S. 2007; Alveolar macrophages are the primary interferon-alpha producer in pulmonary infection with RNA viruses. Immunity 27:240–252 [View Article][PubMed]
    [Google Scholar]
  31. Lai C., Struckhoff J. J., Schneider J., Martinez-Sobrido L., Wolff T., García-Sastre A., Zhang D.-E., Lenschow D. J. 2009; Mice lacking the ISG15 E1 enzyme UbE1L demonstrate increased susceptibility to both mouse-adapted and non-mouse-adapted influenza B virus infection. J Virol 83:1147–1151 [View Article][PubMed]
    [Google Scholar]
  32. Levy D. E., Marié I., Smith E., Prakash A. 2002; Enhancement and diversification of IFN induction by IRF-7-mediated positive feedback. J Interferon Cytokine Res 22:87–93 [View Article][PubMed]
    [Google Scholar]
  33. Manicassamy B., Manicassamy S., Belicha-Villanueva A., Pisanelli G., Pulendran B., García-Sastre A. 2010; Analysis of in vivo dynamics of influenza virus infection in mice using a GFP reporter virus. Proc Natl Acad Sci U S A 107:11531–11536 [View Article][PubMed]
    [Google Scholar]
  34. March C., Moranta D., Regueiro V., Llobet E., Tomás A., Garmendia J., Bengoechea J. A. 2011; Klebsiella pneumoniae outer membrane protein A is required to prevent the activation of airway epithelial cells. J Biol Chem 286:9956–9967 [View Article][PubMed]
    [Google Scholar]
  35. Marsh L. M., Cakarova L., Kwapiszewska G., von Wulffen W., Herold S., Seeger W., Lohmeyer J. 2009; Surface expression of CD74 by type II alveolar epithelial cells: a potential mechanism for macrophage migration inhibitory factor-induced epithelial repair. Am J Physiol Lung Cell Mol Physiol 296:L442–L452 [View Article][PubMed]
    [Google Scholar]
  36. Min J.-Y., Krug R. M. 2006; The primary function of RNA binding by the influenza A virus NS1 protein in infected cells: inhibiting the 2′-5′ oligo (A) synthetase/RNase L pathway. Proc Natl Acad Sci U S A 103:7100–7105 [View Article][PubMed]
    [Google Scholar]
  37. Müller U., Steinhoff U., Reis L. F. L., Hemmi S., Pavlovic J., Zinkernagel R. M., Aguet M. 1994; Functional role of type I and type II interferons in antiviral defense. Science 264:1918–1921 [View Article][PubMed]
    [Google Scholar]
  38. Prakash A., Smith E., Lee C.-K., Levy D. E. 2005; Tissue-specific positive feedback requirements for production of type I interferon following virus infection. J Biol Chem 280:18651–18657 [View Article][PubMed]
    [Google Scholar]
  39. Sakabe S., Ozawa M., Takano R., Iwastuki-Horimoto K., Kawaoka Y. 2011; Mutations in PA, NP, and HA of a pandemic (H1N1) 2009 influenza virus contribute to its adaptation to mice. Virus Res 158:124–129 [View Article][PubMed]
    [Google Scholar]
  40. Sanders C. J., Doherty P. C., Thomas P. G. 2011; Respiratory epithelial cells in innate immunity to influenza virus infection. Cell Tissue Res 343:13–21 [View Article][PubMed]
    [Google Scholar]
  41. Shieh W.-J., Blau D. M., Denison A. M., Deleon-Carnes M., Adem P., Bhatnagar J., Sumner J., Liu L., Patel M. other authors 2010; 2009 pandemic influenza A (H1N1): pathology and pathogenesis of 100 fatal cases in the United States. Am J Pathol 177:166–175 [View Article][PubMed]
    [Google Scholar]
  42. Silverman R. H. 2007; Viral encounters with 2′,5′-oligoadenylate synthetase and RNase L during the interferon antiviral response. J Virol 81:12720–12729 [View Article][PubMed]
    [Google Scholar]
  43. Staeheli P., Haller O., Boll W., Lindenmann J., Weissmann C. 1986; Mx protein: constitutive expression in 3T3 cells transformed with cloned Mx cDNA confers selective resistance to influenza virus. Cell 44:147–158 [View Article][PubMed]
    [Google Scholar]
  44. Stark G. R., Kerr I. M., Williams B. R., Silverman R. H., Schreiber R. D. 1998; How cells respond to interferons. Annu Rev Biochem 67:227–264 [View Article][PubMed]
    [Google Scholar]
  45. Stetson D. B., Medzhitov R. 2006; Type I interferons in host defense. Immunity 25:373–381 [View Article][PubMed]
    [Google Scholar]
  46. Stojdl D. F., Abraham N., Knowles S., Marius R., Brasey A., Lichty B. D., Brown E. G., Sonenberg N., Bell J. C. 2000; The murine double-stranded RNA-dependent protein kinase PKR is required for resistance to vesicular stomatitis virus. J Virol 74:9580–9585 [View Article][PubMed]
    [Google Scholar]
  47. van Boxel-Dezaire A. H. H., Rani M. R. S., Stark G. R. 2006; Complex modulation of cell type-specific signaling in response to type I interferons. Immunity 25:361–372 [View Article][PubMed]
    [Google Scholar]
  48. van Riel D., Munster V. J., de Wit E., Rimmelzwaan G. F., Fouchier R. A. M., Osterhaus A. D. M. E., Kuiken T. 2007; Human and avian influenza viruses target different cells in the lower respiratory tract of humans and other mammals. Am J Pathol 171:1215–1223 [View Article][PubMed]
    [Google Scholar]
  49. Wang X., Hinson E. R., Cresswell P. 2007; The interferon-inducible protein viperin inhibits influenza virus release by perturbing lipid rafts. Cell Host Microbe 2:96–105 [View Article][PubMed]
    [Google Scholar]
  50. Ward S. V., George C. X., Welch M. J., Liou L.-Y., Hahm B., Lewicki H., de la Torre J. C., Samuel C. E., Oldstone M. B. 2011; RNA editing enzyme adenosine deaminase is a restriction factor for controlling measles virus replication that also is required for embryogenesis. Proc Natl Acad Sci U S A 108:331–336 [View Article][PubMed]
    [Google Scholar]
  51. Weidner J. M., Jiang D., Pan X.-B., Chang J., Block T. M., Guo J.-T. 2010; Interferon-induced cell membrane proteins, IFITM3 and tetherin, inhibit vesicular stomatitis virus infection via distinct mechanisms. J Virol 84:12646–12657 [View Article][PubMed]
    [Google Scholar]
  52. Yondola M. A., Fernandes F., Belicha-Villanueva A., Uccelini M., Gao Q., Carter C., Palese P. 2011; Budding capability of the influenza virus neuraminidase can be modulated by tetherin. J Virol 85:2480–2491 [View Article][PubMed]
    [Google Scholar]
  53. Zhan X., Hurwitz J. L., Krishnamurthy S., Takimoto T., Boyd K., Scroggs R. A., Surman S., Portner A., Slobod K. S. 2007; Respiratory syncytial virus (RSV) fusion protein expressed by recombinant Sendai virus elicits B-cell and T-cell responses in cotton rats and confers protection against RSV subtypes A and B. Vaccine 25:8782–8793 [View Article][PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.058438-0
Loading
/content/journal/jgv/10.1099/vir.0.058438-0
Loading

Data & Media loading...

Most cited Most Cited RSS feed